Prevention of Vasovagal Reactions in First-time Blood Donors Using a Combined PSYchological and Physiological Approach (PREDONPSY)

October 2, 2023 updated by: Hospices Civils de Lyon

Prospective Study of the Prevention of Vasovagal Reactions in First-time Whole Blood Donors Using a Combined PSYchological and Physiological Approach: PREDONPSY

The prevention of vasovagal reactions (VVR) occurring during or after donation is a major issue for the French Blood Establishment (EFS), firstly to guarantee the safety of donors but also to retain them, as this reaction is one of the negative experiences affecting the return to donation.

The EVASION study conducted in the Auvergne Rhône-Alpes region (AURA) on 4828 donors representative of the French donor population, reported a beneficial effect of muscle contraction exercises to prevent the occurrence of VVR during donation, while hydric solutions, and even more so isotonic solutions, were likely to decrease the frequency of delayed VVR.

These preventive measures have been integrated into the internal guidelines and currently include muscular and breathing exercises and hydration. Nevertheless, the isotonic solution could not be routinely deployed for feasibility and cost reasons. A salty snack could replace the isotonic solution to produce the same effects with better feasibility and acceptability. Furthermore, a significant proportion of discomfort is psychological in origin, related to stress and anxiety which persist despite these measures, particularly in the first-time donor population.

These measures, which are mainly focused on the prevention of VVR of physiological origin, are still insufficient and can be optimized and complemented to reduce the occurrence of VVR, especially in first-time donors for whom anxiety and stress play an important role in the etiology of VVR.

Two measures could further reduce the occurrence of VVR:

  • Reinforcement of the physiological strategy: ingestion of a salty snack before donation, the effect of which could be similar to the effect of the isotonic solution, which could not be delivered in practice because of its cost following the data of the EVASION study.
  • Addition of a psychological strategy: flyer given at the interview presenting the four most frequent fears as well as a description of the recommended muscular and respiratory exercises, followed by the execution of the recommended exercises before the sampling.

Hypothesis is that the combination of a psychological and physiological strategies would allow a reduction of the occurrence of immediate and/or 48 h delayed VVR during the whole blood donation in first time donors compared to the current practices.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

5320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Lyon, France, 69153
        • French Blood Establishment (EFS)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • M/F between 18 and 70 years old,
  • A first-time donor who wishes to donate blood in Lyon, either at a fixed site or at a mobile unit,
  • Declared fit to donate whole blood after the EFS pre-donation interview,
  • Weight ≥ 50kg and height ≥ 135 cm,
  • Available for telephone contact between to 5d +/- 2 days after donation,
  • Having signed a written consent to participate in the study.

Non-inclusion criteria:

  • Known allergy to shellfish, and/or gluten, and/or milk, and/or soy,
  • Incomprehension of the French language,
  • First-time donor under protective measures (guardian, curator) or any other administrative measure,
  • Not affiliated to the French social security system or any other equivalent system,
  • Pregnant or breastfeeding woman,
  • Subject participating in any other interventional or non-interventional research

Exclusion Criteria:

  • Withdrawal of consent
  • First-time donor with anemia following routine hemoglobin testing
  • First-time donor not reachable for telephone interview

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
EFS usual standard practices for the whole blood donation
Experimental: Test Group 1

A psychological strategy is added to EFS standard practices before the whole blood donation

  • flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises,
  • followed by a training of these exercises and their execution
  • flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises,
  • then realization accompanied by a training of these exercises
Experimental: Test Group 2
A physiological strategy is added to EFS standard practices before the whole blood donation : - Ingesting a salty snack.
- ingesting a salty snack
Experimental: Test group 3

The both psychological and physiological strategies are added to EFS standard practices before the whole blood donation

  • flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises,
  • followed by a training of these exercises and their execution Ingesting a salty snack.
  • flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises,
  • then realization accompanied by a training of these exercises
- ingesting a salty snack

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vasovagal reactions (VVR)
Time Frame: Day 1 = donation day ; Day 3 = 48h post donation
Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by both psychological and physiological strategies (group 4) compared to usual standard practices (group 1)
Day 1 = donation day ; Day 3 = 48h post donation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VVR psychological strategy
Time Frame: Day 1 = donation day ; Day 3= 48h post donation
Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by psychological strategy (group 2) compared to usual standard practices (group 1)
Day 1 = donation day ; Day 3= 48h post donation
VVR physiological strategy
Time Frame: Day 1 = donation day ; Day 3= 48h post donation
Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by physiological strategy (group 3) compared to usual standard practices (group 1)
Day 1 = donation day ; Day 3= 48h post donation
Immediate VVR
Time Frame: Day 1 = donation day, before leaving the centre
Proportion of first-time donors with immediate VVR compared between the groups
Day 1 = donation day, before leaving the centre
Delayed VVR
Time Frame: Day 3= 48h post donation
Proportion of first-time donors with delayed VVR compared between the groups
Day 3= 48h post donation
First-time donor adherence
Time Frame: Day 1 = donation day, before leaving the centre
Adherence of the primary donor to the study strategies and to the EFS recommendations (complete intake of salty snacks, hydration, performance of muscle and breathing exercises training, performance of muscle and breathing exercises during donation, compliance with the duration of post-donation monitoring stage).
Day 1 = donation day, before leaving the centre
First-time donor retention
Time Frame: Month 12 following the first-time donation
Compared between the groups the number of first-time donors who made a second blood donation in the 12 months following the first-time donation, collected by query from the EFS computerized file
Month 12 following the first-time donation
Anxiety/fear
Time Frame: Day 1 = donation day, before donation

Assessment of the evolution of the "anxiety/fear" score between arrival and before the whole blood donation, compared between the groups.

This questionnaire consists of the 6-item Blood Donor Anxiety Scale (BDAS) (5-point Likert scale) (Chell et al., 2016) and a 4-item component with a 5-point Likert scale that allows for an assessment of the 4 most common donor fears (of the needle, to see blood, to feel pain, to experience sensations of discomfort). The scoring is obtained by summing up the responses to the different items.

Score is between 10 and 50, a higher score is associated to a better outcome.

Day 1 = donation day, before donation
Sense of control and fears
Time Frame: Day 1 = donation day, before donation

Assessment of the "sense of control and fears" score, compared between the groups.

The concepts measured here are the feeling of control related to giving blood (5 items) and the feeling of control over fears (4 items) according to a 5-point Likert scale. The scoring is obtained by summing up the answers to the different items.

Score is between 9 and 45, a higher score is associated to a better outcome.

Day 1 = donation day, before donation
Feelings of discomfort
Time Frame: Day 1 = donation day, after donation and before leaving the centre

Assessment of the "feelings of discomfort" score, compared between the groups. The BDRI (Blood Donation Reactions Inventory) (France et al., 2008) provides an assessment of the subjective evaluation of 11 pre-syncopal symptoms (5-point Likert scale). The BDRI is easily understood by donors and is rapid. The BDRI provides important information about the donor experience to predict satisfaction and likelihood of re-donation. The score is calculated by summing up the responses to the various items.

Score is between 11 and 55, a higher score is associated to a worse outcome.

Day 1 = donation day, after donation and before leaving the centre

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 10, 2023

Primary Completion (Estimated)

May 18, 2025

Study Completion (Estimated)

August 18, 2026

Study Registration Dates

First Submitted

August 21, 2023

First Submitted That Met QC Criteria

August 25, 2023

First Posted (Actual)

August 28, 2023

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vasovagal Reaction

Clinical Trials on Psychological strategy

3
Subscribe